Date published: 2026-5-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Myoseverin B (CAS 361431-27-8)

0.0(0)
Write a reviewAsk a question

Alternate Names:
2,6-Bis(4-methoxybenzylamino)-9-cyclohexylpurine
Application:
Myoseverin B is a microtubule-binding molecule
CAS Number:
361431-27-8
Molecular Weight:
472.58
Molecular Formula:
C27H32N6O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Myoseverin B is a compound that functions as a potent inhibitor of microtubule polymerization. It disrupts the dynamic instability of microtubules by binding to the colchicine site, leading to the suppression of microtubule assembly. Myoseverin B′s mechanism of action involves interfering with the normal formation and function of microtubules within the cellular cytoskeleton. By targeting the colchicine site, Myoseverin B prevents the polymerization of tubulin, ultimately leading to the destabilization of microtubules. This disruption of microtubule dynamics can have significant implications for cellular processes that rely on the proper function of the cytoskeleton, potentially impacting cell division, intracellular transport, and cell morphology. In a development setting, Myoseverin B′s ability to interfere with microtubule assembly provide for studying the role of microtubules in various cellular processes. Its specific mechanism of action at the molecular level may be a useful chemical for investigating the mechanisms underlying cytoskeletal dynamics and their impact on cellular function.


Myoseverin B (CAS 361431-27-8) References

  1. Identification of 12Cysbeta on tubulin as the binding site of tubulyzine.  |  Kim, YJ., et al. 2006. Bioorg Med Chem. 14: 1169-75. PMID: 16266809
  2. Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia.  |  Jung, DW. and Williams, DR. 2011. ACS Chem Biol. 6: 553-62. PMID: 21322636
  3. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.  |  Poletto, M., et al. 2016. Mol Carcinog. 55: 688-704. PMID: 25865359
  4. Moving toward a higher efficiency of microcell-mediated chromosome transfer.  |  Liskovykh, M., et al. 2016. Mol Ther Methods Clin Dev. 3: 16043. PMID: 27382603
  5. Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome.  |  Song, L., et al. 2017. Stem Cell Reports. 9: 50-57. PMID: 28648896
  6. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.  |  Grohmann, C., et al. 2021. Cell Death Dis. 12: 268. PMID: 33712556

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Myoseverin B, 1 mg

sc-215407
1 mg
$50.00

Myoseverin B, 5 mg

sc-215407A
5 mg
$280.00